Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Geratherm Medical AGXTER:GME +2.75%72 OCF Margin % is 5.76% as of Dec. 2025, which is 27% below its 10-year median of 7.85. GuruFocus rates XTER:GME with a GF Score™ of 72/100 and a GF Value™ of €3.16 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 815 Medical Devices & Instruments companies, Geratherm Medical AG ranks better than 54.23% on this metric.
The historical rank and industry rank for Geratherm Medical AG's OCF Margin % or its related term are showing as below:
XTER:GME'
s OCF Margin % Range Over the Past 10 Years
Min: 3.59 Med: 7.85 Max: 13.94
Current: 8.13
During the past 13 years, the highest OCF Margin % of Geratherm Medical AG was 13.94%. The lowest was 3.59%. And the median was 7.85%.
XTER:GME's OCF Margin % is ranked better than 54.23% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: 5.75
vs XTER:GME: 8.13
The historical data trend for Geratherm Medical AG's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XTER:GME vs ABT, SYK, MDT: OCF Margin % Comparison
For the Medical Devices subindustry, Geratherm Medical AG's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Geratherm Medical AG OCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Geratherm Medical AG's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Geratherm Medical AG's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Geratherm Medical AG (XTER:GME) has a OCF Margin % of 5.76% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Geratherm Medical AG and its competitors. This is 27% below median its historical median of 7.85. Over the past decade, Geratherm Medical AG's OCF Margin % has ranged from 3.59 to 13.94. According to the industry distribution chart, Geratherm Medical AG ranks #373 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 45.8%.
Is Geratherm Medical AG's OCF Margin % too high?
Geratherm Medical AG's current OCF Margin % of 5.76% is 27% below median its 10-year median of 7.85. Over the past 10 years, this metric has ranged from a low of 3.59 to a high of 13.94. The Medical Devices & Instruments industry median OCF Margin % is 5.75. Geratherm Medical AG's value of 5.76% is 0.2% above this industry median. Based on the distribution chart, Geratherm Medical AG ranks #373 out of 815 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Geratherm Medical AG has a GF Score™ of 72/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Geratherm Medical AG's OCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Geratherm Medical AG ranks #373 out of 815 companies for OCF Margin %. This puts Geratherm Medical AG in the upper half of its industry. The industry median OCF Margin % is 5.75. Geratherm Medical AG's value of 5.76% is 0.2% above this benchmark. Historically, Geratherm Medical AG's own OCF Margin % has ranged from 3.59 to 13.94 over the past decade. While the company's 10-year median is 7.85 vs. the industry median of 5.75, Geratherm Medical AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.75, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Geratherm Medical AG's current OCF Margin % of 5.76% is 0.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Geratherm Medical AG and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Geratherm Medical AG's current OCF Margin % is 5.76%, which is 27% below median its own 10-year median of 7.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Geratherm Medical AG stock overvalued right now?
Based on GuruFocus' analysis, Geratherm Medical AG (XTER:GME) is currently considered Modestly Undervalued. The stock's GF Value™ is €3.16, compared to a current price of €2.62 — trading 17.1% below its estimated fair value. The current OCF Margin % is 5.76%, which is 27% below median its 10-year median of 7.85 and 0.2% above the Medical Devices & Instruments industry median of 5.75. Geratherm Medical AG's overall GF Score™ is 72/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Geratherm Medical AG (XTER:GME), the current OCF Margin % is 5.76% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Geratherm Medical AG (XTER:GME) Overvalued in 2026?
Based on GuruFocus' analysis, Geratherm Medical AG stock appears to be undervalued.
The current stock price of €2.62 is trading 17.1% below its estimated GF Value™ of €3.16.
GuruFocus considers Geratherm Medical AG to be Modestly Undervalued.
Key valuation signals for XTER:GME:
OCF Margin %: 5.76% (27% below median its 10-year median of 7.85)
GF Value™: €3.16 vs. price of €2.62 (17.1% below fair value)
Industry Position: 0.2% above the Medical Devices & Instruments median (#373 of 815)
No single metric tells the full story. See the XTER:GME stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Geratherm Medical AG is a Germany-based medical technology company. The firm operates through four segments: Healthcare Diagnostic, Medical Warming Systems, Cardio/Stroke and Respiratory. Healthcare Diagnostic segment which generates majority revenue provides analog and digital products for measuring body temperature, blood pressure monitors and other products for measuring temperature, as well as related accessories. Medical Warming Systems offers solutions for temperature management at all stages in the pre-clinical and clinical care of the patients, such as rescue situations and operations. Cardio/Stroke segment comprises products for preventing strokes. The Respiratory segment focuses on the development and production of products for pulmonary functional diagnostics.
72GF Score
Get the complete analysis for XTER:GME
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XTER:GME has been successfully added to your 
